15-3SY Novel Targeted Therapies for Eosinophilic Disorders

Friday, 16 October 2015: 14:15 - 14:35
Grand Ballroom 104 (Coex Convention Center)

Shigeharu Ueki, MD, PhD , Dept. of General Internal Medicine and Clinical Laboratory Medicine, Akita Univ. School of Med., Akita-shi, Japan

Learning Objectives:
1, Learn the process by which eosinophils undergo cytolysis to liberate intact cell-free and secretion-competent granules

 2, Discuss the therapeutic possibility for controlling eosinophil cell death type